CompletedNot applicableNCT04915586

Short Duration High Intensity Intrapleural Alteplase With Pulmozyme in Pleural Infection Management

Studying Pleural empyema

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National University of Malaysia
Principal Investigator
Mohamed Faisal Abdul Hamid, MD, PhD
Associate Professor
Intervention
Intra-pleural Alteplase 16mg with Pulmozyme (DNase) 5mg(drug)
Enrollment
30 target
Eligibility
18 years · All sexes
Timeline
2019 – 2020

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04915586 on ClinicalTrials.gov

Other trials for Pleural empyema

Additional recruiting or active studies for the same condition.

See all trials for Pleural empyema →

← Back to all trials